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Fibroblast growth factor (FGF) signalling has been implicated in the generation of mesoderm and neural fates in chordate embryos including
ascidians and vertebrates. In Ciona, FGF9/16/20 has been implicated in both of these processes. However, in FGF9/16/20 knockdown embryos,
notochord fate recovers during later development. It is thus not clear if FGF signalling is an essential requirement for notochord specification in
Ciona embryos. We show that FGF–MEK–ERK signals act during two distinct phases to establish notochord fate. During the first phase, FGF
signalling is required during an asymmetric cell division to promote notochord at the expense of neural identity. Consistently, ERK1/2 is
specifically activated in the notochord precursors following this cell division. Sustained activation of ERK1/2 is then required to maintain
notochord fate. We demonstrate that FGF9/16/20 acts solely during the initial induction step and that, subsequently, FGF8/17/18 together with
FGF9/16/20 is involved in the following maintenance step. These results together with others' show that the formation of a large part of the
mesoderm cell types in ascidian larvae is dependent on signalling events involving FGF ligands.
© 2006 Elsevier Inc. All rights reserved.Keywords: Mesoderm; Notochord; FGF; ERK; Ascidian; CionaIntroduction
The formation of mesoderm represents a critical stage during
animal development. While some of the transcription factors
involved in the process of mesoderm formation in Bilateria
appear to be common (e.g. Brachyury and Snail), the molecular
pathway leading to activation of these transcription factors is
likely different among distinct phyla (reviewed in Technau and
Scholz, 2003). In the case of vertebrates, mesoderm fate
specification is triggered by embryonic induction. A series of
initial experiments by Nieuwkoop suggested that signals
released by vegetal pole cells induce overlying presumptive
ectoderm to form mesoderm in the marginal zone of amphibian
embryos (reviewed in Nieuwkoop, 1977). Nodal proteins,
belonging to the transforming growth factor (TGF)-beta family
of secreted growth factors, constitute a major component of this⁎ Corresponding author. Fax: +33 04 93 76 37 92.
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zebrafish mutants largely devoid of Nodal signals lack head
and trunk mesoderm together with endoderm (Feldman et al.,
1998; Gritsman et al., 1999). We have recently shown that
Nodal signalling is required for the formation of some
mesoderm cell types such as certain mesenchyme, secondary
muscle and secondary notochord precursors in Ciona (Hudson
and Yasuo, 2006). However, Nodal does not appear to be acting
as a generic inducer of mesoderm fates in Ciona. In addition to
Nodal signals, another class of secreted growth factors, the
fibroblast growth factors (FGFs), also plays a pivotal role
during mesoderm formation in vertebrates (reviewed in
Bottcher and Niehrs, 2005). Inhibition of FGF signalling in
Xenopus or zebrafish embryos prevents mesoderm development
in the trunk and tail region (Amaya et al., 1991, 1993; Griffin et
al., 1995). Similarly, mouse embryos mutant for the FGF
receptor 1 (Fgfr1), one of the four known vertebrate FGF
receptors, develop with a reduced amount of posterior
mesoderm (Yamaguchi et al., 1994; Ciruna et al., 1997). A
prominent pathway acting downstream of the FGFR is the Ras/
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components of this pathway blocks the expression of mesoderm
markers (Gupta and Mayer, 1998; MacNicol et al., 1993; Tang
et al., 1995; Whitman and Melton, 1992). Twenty-four genes
encoding FGF ligands have been described so far in tetrapods
(Draper et al., 2003; Itoh and Ornitz, 2004). Several of these
FGF ligands have been implicated in the process of posterior
mesoderm formation. For example, FGF8 and probably FGF4
are involved in posterior mesoderm formation in mice (Sun et
al., 1999). In zebrafish, a combinatorial activity of FGF8 and
FGF24 is responsible for much, if not all, of the FGF signalling
activity controlling the formation of posterior mesoderm
(Draper et al., 2003). Thus, the involvement of the FGF
signalling pathway in the formation of posterior mesoderm is
well established and appears to be well conserved among the
vertebrates.
The role of FGF signalling in mesoderm formation has also
been reported in the invertebrate chordate embryos of ascidians.
Inhibition of the FGF pathway at the level of the receptor, Ras,
MEK (MAP kinase kinase) or Ets transcription factor blocks the
formation of a subset of mesoderm, including notochord,
mesenchyme and caudal muscle in the ascidian Halocynthia
roretzi (Nakatani and Nishida, 1997; Kim and Nishida, 2001,
Miya and Nishida, 2003). Though the identity of the FGF
ligands involved in mesoderm formation remains unknown in
Halocynthia, FGF9/16/20 has been implicated in mesoderm
induction in Ciona savignyi (Imai et al., 2002). Inhibition of
FGF9/16/20 function results in a complete loss of mesenchyme
cells, and the initial specification of the notochord precursors is
also perturbed. Early notochord precursors fail to express the
ascidian homologue of Brachyury (Bra), whose expression is
specific to fate-restricted notochord precursors (Yasuo and
Satoh, 1993; Corbo et al., 1997). However, during gastrulation,
the expression of Bra recovers and a substantial number of
notochord cells finally form. Thus, Imai et al. (2002) proposed
that FGF signals might play a role only during the initial step
of notochord induction and that additional factors might
overcome the inhibition of early FGF signals, leading to the
recovery of some notochord cells during later stages. There-
fore, the exact role of FGF signals in ascidian notochord
formation remains unclear as it appears different between
H. roretzi and C. savignyi.
In this study, we used a third ascidian species, Ciona
intestinalis, a close relative of C. savignyi, in order to address
the precise role of FGF signals in ascidian notochord formation.
We first show that the generation of notochord consists of two
phases in terms of requirement for MEK/ERK signals; the first
phase involves a choice between notochord and neural fates,
while the second phase is required for maintenance of the
specified notochord fate. Using Morpholino antisense oligo-
mediated knockdown, we show that the first phase is mediated
by FGF9/16/20 alone, while the combinatorial activity of FGF9/
16/20 and FGF8/17/18 accounts for the second phase.
Simultaneous inhibition of FGF9/16/20 and FGF8/17/18
function leads to a complete block of notochord formation.
These results demonstrate that FGF signals are essential for
ascidian notochord formation.Materials and methods
Embryo culture and manipulations of C. intestinalis
Adult C. intestinalis were purchased from the Roscoff Marine Biological
Station (Roscoff, France). Embryo culture, microinjection of unfertilised eggs,
cytochalasin (Sigma) and UO126 (Calbiochem) treatments have been described
previously (Hudson et al., 2003). For bFGF treatment, 50 ng/ml recombinant
bFGF (Sigma) was added to artificial sea water containing 0.1% BSA and
applied to embryos from the 64-cell stage. All the data presented in this study
were collected from at least two independent experiments.
In situ hybridisation, probes and immunostaining
In situ hybridisation of Ciona embryos was carried out as described pre-
viously (Wada et al., 1995) with modifications described in Hudson and Yasuo
2006. Dig-probes were synthesised from the following cDNA clones: Ci-Bra
(Corbo et al., 1997); Ci-Noto1 (Hotta et al., 2000); Ci-ETR (Hudson et al.,
2003); Ci-FGF8/17/18 (citb002j04 from the Kyoto Gene Collection Plates;
Satou et al., 2002b); Ci-FoxB (cilv039e20 from the Kyoto Gene Collection
Plates). Immunostaining with anti-dpERK1/2 antibody (Sigma) was carried out
as described in Hudson et al. (2003). Images were captured with a Nikon D70
camera mounted on an Olympus BX51 and processed using Photoshop (Adobe).
Morpholinos
FGF9-MO (5′-CATAGACATTTTCAGTATGGAAGGC-3′; Imai et al.,
2004), FGF8-MO (5′-TGCAAATAGAGGGTCGCATTTTCGT-3′) and Con-
trol-MO (5′-GCATTTGGGCCCAAA-3′) were purchased from GeneTools
LLC and injected at the concentration of 0.5 mM under a Leica S8 APO
stereomicroscope.
Results
MEK signals are required for both initiation and maintenance
of notochord fates in Ciona embryos
Ascidian notochord cells originate from two lineages, the
primary and secondary lineages. In the primary notochord
lineages, fate-restricted notochord precursors are generated at
the 44-cell stage following a cell division of mother cells
resulting in the formation of one notochord and one neural
precursor (Fig. 1). In this study, we are specifically concerned
with the A-line neural lineage, which is the neural lineage
associated with the primary notochord lineage, although neural
fates are also specified from lineages in the animal hemisphere
(reviewed in Lemaire et al., 2002). This cell fate choice between
notochord and neural fates has been shown to operate as a binary
cell fate switch in Halocynthia, with FGF signalling promoting
notochord fate at the expense of neural fates (Minokawa et al.,
2001). Similarly, MEK signals have been implicated in the
specification of notochord fates in C. intestinalis whereby
primary notochord lineages adopt neural fates in the absence of
MEK signals (Hudson et al., 2003). We confirmed and extended
this observation by analysing notochord (Ci-Bra) and neural (Ci-
ETR) fates at the early gastrula stage and notochord fate (Ci-
Noto1) at the early tailbud stage, following inhibition of MEK
signals at precise time points. Ci-Bra encodes a Brachyury T-
box transcription factor required for notochord fate and is the
earliest marker expressed in the fate-restricted notochord
lineages, while Ci-Noto1 has been identified as a target of Ci-
Fig. 1. Diagram showing the primary notochord and A-line neural lineages at the
32- and 44-cell stages. Embryos are viewed from the vegetal pole with their
anterior side upward. Note that ascidian embryos are bilaterally symmetrical.
Each of the A6.2 and A6.4 blastomeres of the 32-cell embryo divides to generate
one primary notochord and one neural precursor. The same colour code will be
used to indicate the primary notochord (orange) and A-line neural (yellow)
lineages in the subsequent figures.
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ELAV-class RNA binding protein and is widely expressed in
both central and peripheral nervous systems during embryo-Fig. 2. Two distinct MEK-dependent phases during notochord formation. In this expe
from different developmental time points indicated above each column until they we
early tailbud stage. (F–I) Expression of Ci-Bra at the early gastrula stage. (K–N) Ex
early gastrula embryo viewed from the vegetal pole. Percentage in each panel sh
corresponding panel, and the remaining embryos were negative (D, H, I) or greatly
expressing the gene is indicated. Data set for Ci-ETR is available in Fig. S1. For thigenesis (Yagi andMakabe, 2001; Hudson et al., 2003). Embryos
were treated with a pharmacological inhibitor UO126 from the
32-, 44-, 64-cell and early gastrula stages. In this experiment, the
32-cell stage corresponded to around 10min before the initiation
of cytokinesis of A6.2 and A6.4 mother cells of notochord and
neural precursors, and the 44-cell stage soon after completion of
this cytokinesis (Fig. 1). Inhibition of MEK signals from the 32-
cell stage onward resulted in the loss of notochord-specific gene
expression (Fig. 2B, G). Expression of Ci-ETR at the early
gastrula stage was concomitantly expanded such that Ci-ETR
was expressed in an average of 14 cells compared to 7.2 cells in
control embryos (Fig. 2K, L and Fig. S1). Judging from the
position of the cells ectopically expressing Ci-ETR, it is most
likely that these are cells in the notochord lineage, indicating that
a cell fate transformation took place. Inhibition of MEK signals
from the 44-cell stage significantly perturbed expression of the
notochord genes. Although 31% of embryos expressed Ci-Bra
at reduced levels (Fig. 2H), expression was not detectable in
69% of embryos. Furthermore, 95% of embryos had undetect-
able Ci-Noto1 expression at early tailbud stages. However,
despite the severe down-regulation of notochord gene expres-
sion following inhibition of MEK from the 44-cell stage, the
notochord cells did not undergo a cell fate transformation from
notochord to neural fate (Fig. 2M). A majority of embryos
treated with UO126 from the 64-cell stage expressed a reduced
level of the notochord-specific genes (94% for Ci-Bra and 61%
for Ci-Noto1, Fig. 2D, I). Inhibition of MEK signals fromriment, embryos were treated with UO126, a pharmacological inhibitor of MEK,
re fixed for in situ hybridisation analyses. (A–E) Expression of Ci-Noto1 at the
pression of Ci-ETR at the early gastrula stage. (J, O) Schematic drawings of the
ows the % of embryos expressing the marker gene to the level shown in the
reduced compared to control (C, E). For Ci-ETR, the average number of cells
s and subsequent figures, ‘n’ indicates total number of embryos analysed.
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expression (Fig. 2E).
These results show that (1) inhibition of MEK signals during
the period of cytokinesis of A6.2 and A6.4 cells leads to a fate
switch from notochord to neural identity in the primary
notochord lineages, and (2) after the separation of notochord
and neural lineages, MEK signals are still required, up to the
onset of gastrulation, for the correct determination of notochord
fate. Thus, MEK signals appear to be required for two distinct
phases during notochord formation.
Spatial activation of ERK1/2 during early cleavage stages
Our observations suggest that MEK–ERK1/2 signals are
required during a prolonged period from the 32-cell until earlyFig. 3. Temporal and spatial pattern of ERK1/2 activation. (A, A′, A″) 32-cell stage
Embryos are viewed from the vegetal pole. Embryonic parts surrounding the mother c
enlarged in panels A″ and B″, respectively, in order to show the asymmetric activation
with arrowheads following the colour scheme in Fig. 1. In the schematic drawings of e
blastomeres are marked with a black dot on the right. dpERK-positive cells in the ear
44-cell embryo is mediated by FGF9/16/20. The percentages in E and F correspond to
remaining FGF9-MO-injected embryos showed reduced levels of ERK activation com
in all nuclei in different batches of embryos (e.g. embryo in C had high background nu
the blastomeres marked on the schematics was clearly and consistently distinguishabl
other blastomeres also possessed lower levels of ERK1/2 activation.gastrula stages for correct specification of the notochord
precursors. Therefore, we next addressed whether the signalling
pathway is indeed active in the notochord precursors during this
period by analysing the spatial pattern of ERK1/2 activation
during these stages. Activation of the MEK–ERK1/2 pathway
can be visualised by immunohistochemical staining with
specific antibodies that recognise phosphorylated ERK1/2
(dpERK1/2), of which there is one representative in the Ciona
genome (Chambon et al., 2002). dpERK1/2 was first detected at
the 32-cell stage in all vegetal blastomeres, including the
notochord/neural mother cells, except the B6.4 blastomeres
(Fig. 3A) (Hudson et al., 2003). At the 44-cell stage (Fig. 3B),
dpERK1/2 was detected in all endoderm precursors (A7.1,
A7.2, A7.5, B7.1 and B7.2) and in the mesenchyme/notochord
mother cells (B7.3). In addition, dpERK1/2 was detected in the. (B, B′, B″) 44-cell stage. (C, C′) 110-cell stage. (D, D′) Early gastrula stage.
ells of notochord/neural precursors and the notochord and neural precursors were
of ERK1/2 following cell division of the mother cells. Blastomeres are labelled
mbryos (A′–D′), blastomere names are shown on the left while dpERK-positive
ly gastrula (D, D′) are of a-line and b-line lineages. (E, F) ERK activation in the
the proportion of embryos with a level of staining represented by the panel. The
pared to control. dpERK1/2 staining produced variable levels of nuclear staining
clear levels whereas the experiment in E and F did not). Nonetheless, staining in
e from this lower ‘background’ level of staining, although we cannot rule out that
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the A7.4 and A7.8 neural precursors (Fig. 3B, Bʺ). This result
shows that, following the cell division of A6.2 and A6.4
notochord/neural mother cells in which ERK1/2 is activated,
only one of the daughter cells maintains active ERK1/2.
Interestingly, asymmetric activation of ERK1/2 between sister
cells also takes place following the cell division of A6.3,
generating dpERK1/2-positive A7.5 (endoderm precursor) and
dpERK1/2-negative A7.6 (‘trunk lateral’ mesenchyme precur-
sor), and that of B6.2, generating dpERK1/2-positive B7.3
(mesenchyme/notochord precursor) and dpERK1/2-negative
B7.4 (muscle precursor), suggesting that asymmetric mainte-
nance of ERK activity may be a common mechanism during the
diversification of cell fates at this stage of development. At the
76- to 110-cell stage, dpERK1/2 becomes barely detectable in
endoderm precursors, but remains in the primary notochord
precursors (Fig. 3C and data not shown). By this stage, the
mesenchyme/notochord mother cell B7.3 has divided to give
rise to one notochord and one mesenchyme precursors.
dpERK1/2 is detected in these two precursors, although the
activation in the mesenchyme precursor becomes weaker or, in
some cases, undetectable by the 110-cell stage (Fig. 3C). Once
gastrulation commences, the phosphorylation of ERK1/2 in the
notochord precursors is down-regulated and becomes undetect-
able in the vegetal blastomeres (Fig. 3D). These data are largely
consistent with the spatial pattern of activation of ERK1/2 in
Halocynthia embryos (Nishida, 2003), although ERK activation
in vegetal blastomeres of the 32-cell embryo was not observed
in Halocynthia.
Therefore, in the primary notochord lineages, ERK1/2 is first
activated in the notochord/neural mother cells in the 32-cell
embryo. Following the division of these mother cells, ERK1/2
activation is observed in the notochord precursors but not the
neural precursors and is maintained until the onset of
gastrulation. The temporal profile of ERK1/2 activation in the
primary notochord lineage is thus entirely consistent with the
temporal requirement of MEK signals for the specification of
notochord precursors from this lineage.
FGF9/16/20 activates the MEK–ERK1/2 pathway and is
required for the choice between notochord and neural fates
There are six FGF genes present in the Ciona genome
(Satou et al., 2002a). It has been shown that FGF9/16/20 plays
critical roles during cleavage stages in the emergence of various
cell types, including anterior neural cells in C. intestinalis
(Bertrand et al., 2003) as well as mesenchyme and early
notochord fates in C. savignyi (Imai et al., 2002). Therefore,
FGF9/16/20 is a very good candidate to be the ligand
responsible for activating the MEK–ERK1/2 pathway in the
notochord precursors. Using Morpholino antisense oligos
(FGF9-MO) to block FGF9/16/20 function, we first addressed
whether the ERK activation in cleaving embryos is dependent
on this FGF ligand. Phosphorylation of ERK1/2 was not
detected in FGF9-MO-injected embryos when analysed at the
44-cell stage (88%; Fig. 3E, F). Consistently, Ci-Bra expression
was not detected at either the 64-cell (100%) or early gastrulastages (93%) (Fig. 4A–C, G–I), which is in agreement with the
observation reported by Imai et al. (2002) in C. savignyi. We
then asked whether the primary notochord precursors adopt a
neural fate, in FGF9-MO-injected embryos. We used two genes
as markers, Ci-FoxB at the 64-cell stage and Ci-ETR at the early
gastrula stage. Ci-FoxB encodes a winged helix loop helix
transcription factor and starts to be expressed in A-line neural
precursors and trunk lateral cell precursors from the 64-cell
stage (Imai et al., 2004). Following injection of FGF9-MO, both
Ci-FoxB and Ci-ETR were ectopically expressed in the primary
notochord lineages as well as in the neural lineages, with
ectopic expression of Ci-FoxB also detected in anterior
endoderm (Fig. 4D–F, J–L and Fig. S1). This result suggests
that, in the absence of FGF9/16/20 function, primary notochord
lineages adopt the fate of the A-line neural precursors.
Thus, the effect of FGF9/16/20 knockdown on the decision
between notochord and neural fates appears to be identical to
that following early inhibition of MEK signals, suggesting that
FGF9/16/20 is the sole FGF ligand activating the pathway
during this initial phase of primary notochord formation.
FGF/MEK signalling is required to repress muscle fate in the
secondary notochord precursors
While we have focused our study on the formation of the
primary notochord lineage, FGF signals are also implicated in
the formation of the so-called ‘secondary’ notochord, which
give rise to the posterior-most eight notochord cells of the larva.
While the primary notochord is specified following a cell fate
choice with neural fate, the secondary notochord lineage is
associated with muscle and mesenchyme fates. The secondary
notochord precursor, B8.6, forms at the 76-cell stage and is
generated following two rounds of cell divisions of the B6.2
blastomere of the 32-cell embryo. B6.2 divides to give rise to
one muscle precursor (B7.4) and one precursor of mixed
mesenchyme and secondary notochord fate (B7.3). B7.3 then
divides to generate one mesenchyme (B8.5) and one secondary
notochord (B8.6) precursor at the 76-cell stage. The secondary
notochord precursors are specified via a relay mechanism
involving FGF9/16/20, Nodal and Delta ligands whereby
FGF9/16/20 induces Nodal, Nodal induces Delta2 and Delta2
induces Bra (Hudson and Yasuo, 2005, 2006). In the absence of
either Nodal or Delta2 activity, the secondary notochord
precursor adopts neither notochord, muscle nor mesenchyme
fate, the last two of which are the fates of its sister blastomeres
during the two rounds of cell division from the 32-cell stage. In
H. roretzi, it has been shown that, in the absence of FGFR/Ras/
MEK signals, the mesenchyme/notochord mother cell trans-
forms into muscle (Kim and Nishida, 2001). In contrast, in
Ciona savigni and C. intestinalis, it has been reported that,
following inhibition of FGF9/16/20, only the B8.5 mesenchyme
precursor, and not the B8.6 secondary notochord precursor,
adopts muscle fate (Imai et al., 2002; Imai et al., 2006). In order
to address if MEK signals are implicated in the repression of
muscle fate in the secondary notochord of C. intestinalis
embryos, we analysed the expression of a Ciona homologue of
bHLH myogenic regulatory genes, Ci-Mdf, at the 110-cell stage
Fig. 4. FGF9/16/20 is the sole ligand responsible for the fate decision of the primary notochord lineage. FGF9-MO-injected embryos were analysed for expression of
Ci-Bra (A–C) and Ci-FoxB (D–F) at the 64-cell stage and Ci-Bra (G–I), Ci-ETR (J–L) and Ci-Mdf (M–O) at the early gastrula stage. (A, D, G, J, M) Control un-
injected embryos. (B, E, H, K, N) Schematic drawings of embryos representing expression, in control embryos, of the marker gene indicated on the left of each row of
panels. Expression is represented by coloured blastomeres. Black dots in panel E indicate trunk lateral mesenchyme precursors that also express Ci-FoxB. (C, F, I, L,
O) FGF9-MO-injected embryos. All embryos are viewed from the vegetal pole, except those in the insets in panels D and F, which are anterior–vegetal views. Inserts
in panels D and F are embryos tilted slightly so that the primary notochord and A-line neural lineages are in the same focal plane. In panels N and O, arrowheads point
to the B8.6 secondary notochord precursor and the arrow to the B8.5 mesenchyme precursor. Percentages correspond to the percentage of embryos that the panel
represents following the treatment indicated above the panels. For panels A and G, the remaining embryos showed no expression. For panels F and I, the remaining
28% and 7% of embryos expressed Ci-FoxB and Ci-Bra as controls, respectively. For Ci-ETR expression, the average number of A-line cells expressing the gene is
shown. Data set for Ci-ETR is available in Fig. S1. Data for Ci-Mdf are represented in Table 1.
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Fig. 4M–O) (Meedel et al., 1997). We found that, similar to the
situation in Halocynthia, inhibition of MEK signals with
UO126 did indeed lead to a transformation of both the
mesenchyme and secondary notochord precursors into musclefate (Table 1). In addition, we found that inhibition of FGF9/16/
20 led to the transformation of both B8.5 and B8.6 into muscle
fate (Fig. 4M–O; Table 1). The transformation of the B8.6
notochord precursors may have been missed in the previous
studies (Imai et al., 2002; Imai et al., 2006) since these
Table 1
The secondary notochord adopts muscle fate when FGF signals are blocked
Control U0126 FGF9-MO FGF8+9-MOs
+ w n + w n + w n + w n
B8.5 mes 0% 38 97% 74 82% 6% 62 89% 4% 56
B8.6 noto 0% 96% 1% 60% 19% 89% 4%
Expression of Mdf in B8.5 mesenchyme or B8.6 secondary notochord
precursors following inhibition of MEK, FGF9 or FGF8 plus FGF9. Expression
is shown as a percentage of embryos showing strong (+) or weak (w) expression
of Mdf in one or both blastomeres. n=total number of embryos analysed.
Fig. 5. Recovery of notochord cells in FGF9-MO embryos is dependent on
MEK signals. (A–D) Expression of Ci-Bra (A, B) and Ci-Noto1 (C, D) is
recovered in FGF9-MO embryos when analysed at the late gastrula and early
tailbud stages, respectively. The number and percentages for this set of
experiments can be found in Fig. 6. (E–H) Expression of Ci-Noto1 at the early
tailbud stage in embryos treated with cytochalasin from the 64-cell stage. For
each experiment, the average number of cells positive for Ci-Noto1 expression
is indicated. (E) Control un-injected embryos. The inset shows a control
cleaving embryo. (F) FGF9-MO-injected embryos. Ci-Noto1 positive cells were
observed in both lateral (shown) and medial positions. (G) Embryos treated with
UO126 from the 64-cell stage. (H) FGF9-MO-injected embryos treated with
UO126 from the 64-cell stage. Data set for the experiments represented in E–H
is available in Fig. S1.
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B8.5 mesenchyme precursors in FGF9-MO embryos (Table 1).
This result shows that, during the specification of the secon-
dary notochord precursor, FGF9/16/20 acts by both activating
the Nodal–Delta2 signalling relay (Hudson and Yasuo, 2006)
and repressing muscle fate in the secondary notochord
precursor.
FGF8/17/18 functions together with FGF9/16/20 to maintain
notochord fate
Imai et al. (2002) reported that expression of notochord gene
markers recovered at later stages in C. savignyi embryos
injected with FGF9-MO. Despite the apparent switch of
notochord cells to A-line neural fate, we confirmed that this
was also the case in C. intestinalis. We found that expression of
Ci-Bra at the late gastrula was detected in around 38% of
embryos and Ci-Noto1 at the early tailbud stage in 55% of
embryos, although, in these cases, the number of cells
expressing these genes was smaller than in sibling control
embryos (Fig. 5A–D and Fig. 6B, C). Therefore, at later stages,
FGF9/16/20 knockdown and MEK inhibition from the 32-cell
stage with UO126 exhibit distinct effects on notochord
formation. In order to address the embryonic origin of the
recovered notochord cells, embryos injected with FGF9-MO
were placed in cytochalasin B at the 64-cell stage and analysed
for Ci-Noto1 expression at the early tailbud stage. This
procedure allows one to identify blastomere lineages in
perturbed embryos as blastomeres retain their relative positions
from the stage of cleavage arrest (Whittaker, 1977). Following
this procedure, we could ascertain that the recovered notochord
fate was indeed arising from the primary notochord lineage
(Fig. 5E, F). We then asked whether this recovery was
dependent on a later acting MEK signalling pathway. Inhibition
of MEK signalling from the 64-cell stage, a procedure that
normally results in only a reduced expression of notochord
marker genes (Figs. 2D, I and 5G), was able to suppress
notochord recovery in FGF9-MO-injected embryos (Fig. 5G, H
and Fig. S1). This result indicates that, even following
inhibition of FGF9/16/20 function, MEK signals become active
during later stages and are sufficient to recover some notochord
fate in the primary notochord lineage. We therefore hypothe-
sised that another FGF ligand was cooperating with FGF9/16/
20 during the second phase of notochord formation and sought
to identify this ligand.We would predict that a candidate ligand should be
expressed sometime from the 64-cell stage and be in close
proximity to the notochord cells. FGF8/17/18 starts to be
expressed at the 64-cell stage strongly in ‘trunk lateral’
mesenchyme cells and weakly in anterior endoderm precursors,
which underlie the primary notochord precursors, and this
expression is maintained until the beginning of gastrulation
(Fig. 6A; Imai et al., 2004). Thus, the temporal and spatial
profile of FGF8/17/18 expression makes it a good candidate for
the second FGF signal that may account for the MEK-
dependent recovery of notochord in FGF9-MO-injected
embryos. In order to address the role of FGF8/17/18 during
Fig. 6. FGF9/16/20 and FGF8/17/18 together are essential for notochord formation. (A) Expression pattern of Ci-FGF8/17/18 in 64- and 110-cell embryos. Ci-FGF8/
17/18 positive cells are marked with dots with a gray scale indicating signal intensity in the schematic drawings (bottom panels). (B, C) Expression of Ci-Bra (B) and
Ci-Noto1 (C) at the late gastrula and early tailbud stage, respectively, was analysed in embryos injected with either FGF9-MO alone, FGF9-MO plus Control-MO,
FGF9-MO plus FGF8-MO or FGF9-MO plus FGF8-MO followed by treatment with bFGF proteins from the 64-cell stage. Embryos were classified into four types
depending on expression levels of the genes, as indicated in the panels. The percentages of embryos for each class following each treatment are shown on the graphs
with different colours corresponding to different classes.
99H. Yasuo, C. Hudson / Developmental Biology 302 (2007) 92–103
100 H. Yasuo, C. Hudson / Developmental Biology 302 (2007) 92–103notochord formation, we utilised Morpholino antisense oligos
against FGF8/17/18 (FGF8-MO). Injection of FGF8-MO did
not cause apparent defects in embryogenesis as larval stage
embryos appeared normal in gross morphology and Ci-Bra
expression at the early gastrula stage was not affected (data not
shown). However, co-injection of FGF8-MO together with
FGF9-MO resulted in the suppression of the notochord
recovery that was observed when FGF9-MO was injected
alone or in combination with Control-MO (Fig. 6B, C).
Furthermore, replacing FGF signals from the 64-cell stage by
application of recombinant bFGF proteins to embryos co-
injected with FGF9-MO and FGF8-MO resulted in a recovery
of notochord formation to similar levels seen in embryos
injected with FGF9-MO alone (Fig. 6B, C). These results
suggest that, under certain circumstances, late FGF signalling is
sufficient to induce some notochord fate and that some
notochord cells remain competent beyond the 64-cell stage
and are able to adopt notochord fate in response to this FGF
signalling.
Taken together, our results suggest that, while FGF9/16/20 is
responsible for the early phase of notochord induction, both
FGF9/16/20 and FGF8/17/19 appear to act together during a
later reinforcement/maintenance phase of notochord formation
(Fig. 7). Similarly, FGF8/17/18 may also cooperate with FGF9/
16/20 during repression of muscle fate in the B8.6 secondary
notochord precursor since inhibition of both FGF9/16/20 and
FGF8/17/18 resulted in a higher level of transformation of
secondary notochord into muscle fate than following FGF9/16/
20 inhibition alone (Table 1).Fig. 7. A model for the role of FGF9/16/20 and FGF8/17/18 ligands during generatio
indicated with blue dots, activates the MEK–ERK1/2 pathway in the notochord/ne
restricted notochord precursors at the 44-cell stage (light orange). ERK activation in th
neural fate in these cell lineages. Sustained FGF signals are required until the beginn
expression is marked with red dots, functions together with FGF9/16/20 during thisDiscussion
The role of FGF signals in ascidian notochord formation has
been a controversial issue. Studies carried out in H. roretzi
strongly support a role, while those in C. savignyi raised the
possibility that the requirement of FGF signals for notochord
formation is not absolute. Our results show that MEK/ERK
signals are involved in two phases of notochord formation in C.
intestinalis; firstly, during specification of notochord fate
involving a choice between notochord and neural fates, and
secondly, during maintenance/reinforcement of the specified
notochord fate (Fig. 7). We have described the spatial and
temporal pattern of ERK1/2 activation during these phases,
which is consistent with the proposed role of MEK/ERK
signals. Finally, we have shown that the early phase is mediated
by FGF9/16/20 alone, while an additional FGF ligand, FGF8/
17/18, appears to act cooperatively with FGF9/16/20 during the
second phase. These results provide definitive evidence that the
FGF signalling pathway is essential for ascidian notochord
formation.
Mesoderm formation in ascidian embryos
A limited number of mesoderm cell types are present in
ascidian larvae, including notochord, muscle and mesenchyme,
which consist of 40, 36 and about 900 cells, respectively. Both
notochord and muscle cells have two distinct lineage origins,
the primary and secondary lineages, of which the primary
lineages generate the majority of larval tissues and then of notochord fate in Ciona embryos. FGF9/16/20, whose expression domain is
ural precursors at the 32-cell stage (coloured in dark orange) and in the fate-
e notochord precursors leads to both adoption of notochord fate and repression of
ing of gastrulation for full determination of notochord fate. FGF8/17/18, whose
latter process.
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the tip of the tail.
Ascidian embryogenesis has long been regarded as an
example of ‘mosaic’ development. The primary muscle cells
inherit a mitochondria-rich cytoplasmic domain of the egg,
called the myoplasm, following successive asymmetric cell
divisions (Conklin, 1905). It has been shown that cell
fragments enriched with myoplasm can promote muscle fate
when fused to a cell of epidermal lineage (Nishida, 1992).
This is a classic example of an embryonic determinant
operating during a mosaic mode of development. However,
apart from the primary muscle, it is now known that
generation of all the other mesoderm cell types including
mesenchyme, secondary muscle and notochord depends on
cell signalling. FGF9/16/20 appears to be the sole FGF ligand
required for mesenchyme induction (Imai et al., 2002).
Activation of ERK in mesenchyme precursors supports the
notion that the action of FGF9/16/20 may be direct (Fig. 3). In
addition, the formation of the secondary notochord, the
secondary muscle and some mesenchyme fates depends on
FGF signals, which appear to be relayed by FGF9/16/20-
dependent activation of Nodal (Hudson and Yasuo, 2006).
Finally, in this study, we have shown that both FGF9/16/20
and FGF8/17/18 are responsible for the specification of the
primary notochord. The presence of activated ERK1/2 in the
primary notochord cells during a prolonged period supports
the idea that these FGF signals are acting directly on the
notochord precursors. Thus, it appears that, apart from primary
muscle, all mesoderm lineages of ascidians are dependent
upon FGF signalling.
FGF ligands and chordate mesoderm formation
So far, 24 FGF genes have been identified in vertebrates
and can be phylogenetically divided into 7 subclasses,
including FGF1, FGF4, FGF7, FGF8, FGF9, FGF11 and
FGF19 subclasses (Itoh and Ornitz, 2004; see also Popovici
et al., 2005). FGF ligands implicated so far in vertebrate
mesoderm formation belong to the FGF8 or FGF4 subclasses.
In zebrafish, two FGF ligands belonging to the FGF8 subclass,
FGF8 and FGF24, are responsible for much of the FGF signals
required for the formation of posterior mesoderm (Draper et
al., 2003). Similarly, mouse mutants for FGF8 do not form
posterior mesoderm, although this effect might be due to a loss
of both FGF8 and FGF4 since the FGF8 mutant embryos do
not express the FGF4 gene. Morpholino-mediated gene
knockdown experiments in Xenopus have also revealed an
essential role for FGF8 in mesoderm formation (Fletcher et al.,
2006). In particular, it has been shown that an isoform of
FGF8, FGF8b, generated via alternative splicing, is required
for mesoderm formation, while another isoform, FGF8a, is not
involved in this process (Fletcher et al., 2006; Hardcastle et al.,
2000). In Xenopus, FGF4 (eFGF) plays a role during
maintenance of muscle fate during gastrulation, a process
referred to as a ‘community effect’ (Standley et al., 2001;
Fisher et al., 2002). In the genome of C. intestinalis, 6 FGF
genes are present (Satou et al., 2002a). These are Ci-FGF3/7/10/22 (FGF7 subclass), Ci-FGF4/5/6 (FGF4 and FGF19
subclasses), Ci-FGF8/17/18 (FGF8 subclass), Ci-FGF9/16/20
(FGF9 subclass), Ci-FGF11/12/13/14 (FGF11 subclass) and
Ci-FGF-L, which may be another member of the FGF4
subclass (Popovici et al., 2005; but see Satou et al., 2002a and
Itoh and Ornitz, 2004). In this study, we showed that Ci-FGF8/
17/18 is involved in the maintenance of induced notochord
fate. Thus, FGF8 class ligands are implicated in mesoderm
formation in both vertebrates and ascidians, although the role
of FGF8 in ascidian embryos is rather minor compared to that
in vertebrate embryos. In Ciona, an FGF9 class ligand, Ci-
FGF9/16/20, accounts for the majority of the FGF signals
required for mesoderm formation. On the other hand, in
vertebrates, FGF9 knockout experiments have implicated
FGF9 in sex determination and lung and cecum development
(Colvin et al., 2001a,b; Zhang et al., 2006). It will now be
important to assess if other members of the FGF9 class
ligands play any role during vertebrate mesoderm formation.
Indeed, it has been recently shown that FGF20, a member of
the FGF9 subclass, is a transcriptional target of the canonical
Wnt pathway and is expressed in the marginal zone of Xe-
nopus late blastula embryos (Chamorro et al., 2005).
Altogether, although it is clear that the critical role of FGF
signalling during formation of the mesoderm is well
conserved, the identity of the principal ligand responsible for
this induction may differ in ascidians and vertebrates.
Choice between neural and mesoderm fates
In ascidian embryos, primary notochord precursors are
specified following a choice between notochord and neural fates
with FGF–MEK–ERK signals promoting notochord fate (this
study; Minokawa et al., 2001). Similarly, it has been shown that,
in vertebrates (mouse, chick and zebrafish), gastrulating cells
may also undergo a choice between neural and mesodermal
identities (Ciruna et al., 1997; Yoshikawa et al., 1997; Chapman
and Papaioannou, 1998; Feldman et al., 2000; Sheng et al.,
2003).
As FGF signals are required for both mesoderm and neural
fates (reviewed in Stern, 2005), one could wonder how the
same signalling pathway can elicit two distinct cellular
responses. One could envisage that these differences could
be mediated by different FGF ligands activating different
transduction pathways, differential competence within the
responding cells or differential signalling intensity. In chick
embryos, an underlying mechanism whereby the same FGF
signal can act to promote two distinct cell types was elegantly
revealed by the identification of Churchill, a zinc finger
transcription factor (Sheng et al., 2003). Churchill is induced
as a slow transcriptional response to FGF signals and in turn
activates Smad-interacting protein-1 (Sip1), a direct transcrip-
tional repressor of Brachyury (Lerchner et al., 2000; Papin
et al., 2002; Verschueren et al., 1999; Sheng et al., 2003).
Churchill thereby alters the cellular response to FGF from a
mesoderm response to a neural response. A similar role for
Churchill in other vertebrates, including Xenopus where the
gene is present, has not yet been reported. Rather, it has been
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between presumptive neuroectoderm and mesoderm territories
of the pre-gastrula frog embryo could account for separation of
these two cell types with high-level FGF signalling being
required for mesoderm fate and low-level signalling for neural
fate (Delaune et al., 2004). This scenario is consistent with
both the graded pattern of ERK activation along the animal–
vegetal axis observed in Xenopus and the observation that
exogenous FGF8 proteins can travel for several cell diameters
in zebrafish embryos (Schohl and Fagotto, 2002; Scholpp and
Brand, 2004).
In Ciona, FGF signalling, acting before the onset of
gastrulation, is also required for the specification of subsets of
neural and mesoderm fates (this study; Bertrand et al., 2003;
Imai et al., 2002). FGF signals are required for specification of
both notochord, following a notochord-neural fate choice in
anterior vegetal (A-line) cells, and neural fates, following a
neural-epidermal fate choice in anterior animal (a-line) cells.
There is no clear homologue of Churchill in the Ciona genome.
In Ciona, the differential response of primary notochord and a-
line neural lineages to FGF signals appears to be controlled by
specific responses to FGF between these lineages. In the animal
hemisphere, this difference is mediated by GATAa transcription
factor (Bertrand et al., 2003). Differential activation of ERK
between the primary notochord and A-line neural precursors and
between the a-line neural and epidermal precursors suggests that
these fate choices may operate in response to a simple ON/OFF
switch of ERK activity (this study; Hudson et al., 2003). In
ascidians, these cell types are specified at early cleavage stages
(at the 32- to 44-cell stages) before any cell movements
associated with gastrulation take place and concern only a small
number of cells. In addition, because these cell fate choices are
occurring in different embryonic lineages, the requirement for
differential levels of FGF could easily be bypassed by adopting
instead simple ON/OFF switches between the different sister
lineages.
It has been shown that the ON/OFF state of ERK activation
between a-line neural and a-line epidermal precursors is
achieved through a simple threshold response to a difference
in the area of cellular contact between these blastomeres and the
FGF9/16/20-expressing vegetal cells (Tassy et al., 2006). On
the other hand, it remains to be understood how the ON/OFF
state of ERK activation between primary notochord and A-line
neural precursors is established since FGF9/16/20 is rather
broadly expressed among vegetal cells, including the mother
cells of the two precursors at the 32-cell stage. The mechanism
responsible for the restriction of ERK activity to only one
daughter cell thus constitutes an important topic for future
studies.
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